Autres langues AstraZeneca PLC

Actions

AZN

GB0009895292

Produits pharmaceutiques

Temps réel estimé Cboe Europe Autres places de cotation 11:46:23 30/07/2026			Varia. 5j.	Varia. 1 janv.
12 943,00 ^GBX	-1,45%		+2,16%	-6,00%

08:43	Avis d'analystes du jour : du nouveau sur Airbus, Galderma et Sopra Steria
07:39	Le Nasdaq se fait corriger

Autres langues

07:01	Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trials
29/07	Deutsche Bank cuts Diageo and Luceco
29/07	DKSH erweitert Partnerschaft mit Novartis für Blutdruckmedikamente in Korea
28/07	GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline -- Update
28/07	GSK to invest £400 million in Britain over three years as it ramps up R&D efforts
28/07	Lepu Biopharma, AstraZeneca Cancer Drug Meets Phase 3 Survival Goal
28/07	AstraZeneca Kept at Buy as Berenberg Notes 'Upbeat' Q2 Earnings Call
28/07	Hong Kong Stocks Edge Higher Ahead of Central Bank Meetings; Keymed Biosciences Falls
28/07	Citi ups Admiral; Peel Hunt cuts Sabre
28/07	Keymed Biosciences' Gastric Cancer Drug Meets Phase 3 Goal; Shares Fall 5%
28/07	MORNING BRIEFING - Deutschland/Europa
28/07	Hong Kong-listed Keymed Biosciences' gastric cancer drug meets late-stage trial goals
27/07	Health Care Up Amid Deal Activity -- Health Care Roundup
27/07	Bolsas europeas se mantienen estables, debilidad de tecnológicas contrarresta optimismo sobre EEUU-Irán
27/07	European shares steady as tech weakness offsets US-Iran optimism
27/07	Uneinheitlich - Ölpreis-Rpückgang stützt - Schwacher Tech-Sektor
27/07	Stocks jump as US-Iran pause sees oil price fall
27/07	Top Midday Stories: Nvidia Enters Into $500 Billion Partnership With SK Group; AstraZeneca Earnings Top Estimates
27/07	Aktien Europa Schluss: Tech-Sorgen bremsen Ölpreis-Euphorie
27/07	European Stocks Close Higher in Monday Trading as Oil Prices Plunge on Pause in Fighting
27/07	British Equities Gain on Corporate Activity, Easing Middle East Tensions
27/07	Astrazeneca Rises on Profit Beat; Paramount Pauses WBD Deal \| Stock Movers
27/07	ASTRAZENECA : In line Q2; correction of late is an entry point
27/07	Enhertu(R) Plus Pertuzumab Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with HER2 Positive Metastatic Breast Cancer
27/07	Afternoon Meeting: La semana en la que todo confluye en Wall Street